| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosome Aberrations | 57 | 2022 | 574 | 5.890 |
Why?
|
| Chromosome Deletion | 62 | 2019 | 653 | 5.340 |
Why?
|
| Comparative Genomic Hybridization | 74 | 2020 | 568 | 4.600 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 50 | 2025 | 995 | 4.190 |
Why?
|
| DNA Copy Number Variations | 49 | 2025 | 1022 | 3.340 |
Why?
|
| Abnormalities, Multiple | 45 | 2018 | 964 | 3.070 |
Why?
|
| Chromosome Disorders | 32 | 2025 | 317 | 3.030 |
Why?
|
| Gene Duplication | 36 | 2016 | 358 | 2.960 |
Why?
|
| Developmental Disabilities | 40 | 2018 | 780 | 2.890 |
Why?
|
| In Situ Hybridization, Fluorescence | 68 | 2022 | 742 | 2.720 |
Why?
|
| Mosaicism | 22 | 2022 | 248 | 2.500 |
Why?
|
| Prenatal Diagnosis | 36 | 2025 | 615 | 2.400 |
Why?
|
| Translocation, Genetic | 20 | 2022 | 344 | 2.350 |
Why?
|
| Intellectual Disability | 37 | 2018 | 1085 | 2.020 |
Why?
|
| Chromosomes, Human, X | 17 | 2019 | 154 | 1.990 |
Why?
|
| Chromosome Duplication | 12 | 2017 | 147 | 1.990 |
Why?
|
| Gene Dosage | 31 | 2015 | 436 | 1.870 |
Why?
|
| Nucleic Acid Hybridization | 22 | 2016 | 296 | 1.850 |
Why?
|
| Karyotyping | 40 | 2025 | 308 | 1.750 |
Why?
|
| Gene Rearrangement | 17 | 2025 | 321 | 1.640 |
Why?
|
| Phenotype | 52 | 2019 | 4471 | 1.600 |
Why?
|
| Exons | 14 | 2025 | 762 | 1.600 |
Why?
|
| Genome, Human | 35 | 2025 | 1313 | 1.430 |
Why?
|
| Gene Deletion | 17 | 2015 | 767 | 1.400 |
Why?
|
| Chromosomes, Human, Pair 15 | 13 | 2018 | 143 | 1.360 |
Why?
|
| Chromosomes, Human, Pair 14 | 8 | 2019 | 95 | 1.330 |
Why?
|
| Chromosomes, Human, Pair 17 | 14 | 2015 | 363 | 1.230 |
Why?
|
| Chromosomes, Human, Pair 16 | 11 | 2018 | 148 | 1.180 |
Why?
|
| Cytogenetic Analysis | 12 | 2025 | 78 | 1.100 |
Why?
|
| Sequence Deletion | 21 | 2018 | 518 | 1.090 |
Why?
|
| Language Development Disorders | 12 | 2017 | 177 | 1.080 |
Why?
|
| Child, Preschool | 81 | 2019 | 14949 | 1.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 7 | 2016 | 67 | 1.030 |
Why?
|
| Humans | 255 | 2026 | 130342 | 0.970 |
Why?
|
| Female | 182 | 2025 | 70331 | 0.920 |
Why?
|
| Child Development Disorders, Pervasive | 4 | 2014 | 82 | 0.910 |
Why?
|
| Chromosomes, Human, Pair 1 | 11 | 2014 | 145 | 0.890 |
Why?
|
| Microarray Analysis | 15 | 2020 | 223 | 0.890 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2015 | 284 | 0.860 |
Why?
|
| Sex Chromosome Aberrations | 8 | 2021 | 59 | 0.860 |
Why?
|
| Trisomy | 8 | 2025 | 112 | 0.840 |
Why?
|
| Segmental Duplications, Genomic | 11 | 2015 | 81 | 0.840 |
Why?
|
| Male | 151 | 2025 | 64409 | 0.830 |
Why?
|
| Infant | 63 | 2018 | 13239 | 0.820 |
Why?
|
| Genomics | 12 | 2025 | 1612 | 0.800 |
Why?
|
| Syndrome | 22 | 2019 | 1159 | 0.790 |
Why?
|
| Microcephaly | 11 | 2018 | 348 | 0.790 |
Why?
|
| Nerve Tissue Proteins | 11 | 2018 | 1081 | 0.790 |
Why?
|
| Chromosome Inversion | 6 | 2020 | 70 | 0.790 |
Why?
|
| Chromosome Mapping | 21 | 2020 | 1046 | 0.770 |
Why?
|
| Autistic Disorder | 11 | 2018 | 395 | 0.760 |
Why?
|
| Ring Chromosomes | 1 | 2022 | 12 | 0.750 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2015 | 108 | 0.740 |
Why?
|
| Telomere | 6 | 2013 | 217 | 0.740 |
Why?
|
| Chromosomes, Human, Pair 11 | 5 | 2011 | 87 | 0.720 |
Why?
|
| DNA | 12 | 2016 | 1400 | 0.700 |
Why?
|
| Child | 77 | 2020 | 26097 | 0.700 |
Why?
|
| Chromosome Banding | 18 | 2025 | 135 | 0.690 |
Why?
|
| Pregnancy | 49 | 2025 | 7418 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2014 | 137 | 0.680 |
Why?
|
| X Chromosome Inactivation | 7 | 2019 | 59 | 0.670 |
Why?
|
| Pedigree | 20 | 2020 | 1672 | 0.620 |
Why?
|
| Chromosomes, Human, Pair 18 | 4 | 2014 | 59 | 0.600 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2018 | 82 | 0.570 |
Why?
|
| Sequence Analysis, DNA | 18 | 2025 | 1694 | 0.570 |
Why?
|
| Chromosome Breakage | 15 | 2011 | 154 | 0.570 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 61 | 0.540 |
Why?
|
| Cognition Disorders | 5 | 2013 | 554 | 0.530 |
Why?
|
| Chromosomes, Human, Y | 4 | 2014 | 52 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 9 | 7 | 2012 | 109 | 0.520 |
Why?
|
| Introns | 2 | 2015 | 279 | 0.500 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2018 | 211 | 0.500 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 562 | 0.500 |
Why?
|
| Chromosomes, Human, Pair 3 | 4 | 2013 | 89 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2019 | 2824 | 0.480 |
Why?
|
| Genetic Testing | 7 | 2019 | 1099 | 0.480 |
Why?
|
| Chorionic Villi | 6 | 2016 | 20 | 0.480 |
Why?
|
| Adolescent | 44 | 2018 | 20718 | 0.480 |
Why?
|
| Aneuploidy | 8 | 2021 | 136 | 0.480 |
Why?
|
| WAGR Syndrome | 2 | 2006 | 7 | 0.470 |
Why?
|
| DiGeorge Syndrome | 3 | 2012 | 83 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2016 | 53 | 0.470 |
Why?
|
| Hernia, Diaphragmatic | 5 | 2011 | 91 | 0.470 |
Why?
|
| Diagnosis | 1 | 2016 | 29 | 0.470 |
Why?
|
| Sex Chromosome Disorders | 2 | 2015 | 9 | 0.470 |
Why?
|
| Base Sequence | 22 | 2016 | 2737 | 0.460 |
Why?
|
| False Positive Reactions | 2 | 2015 | 142 | 0.460 |
Why?
|
| Chromosomes, Human | 7 | 2020 | 120 | 0.460 |
Why?
|
| Growth and Development | 1 | 2015 | 20 | 0.460 |
Why?
|
| Proteins | 4 | 2018 | 1008 | 0.460 |
Why?
|
| Mutagenesis, Insertional | 2 | 2020 | 150 | 0.450 |
Why?
|
| Epilepsy | 9 | 2018 | 862 | 0.450 |
Why?
|
| Adult | 55 | 2025 | 31121 | 0.440 |
Why?
|
| Amniotic Fluid | 10 | 2016 | 146 | 0.430 |
Why?
|
| Fetal Diseases | 4 | 2018 | 441 | 0.430 |
Why?
|
| Infant, Newborn | 26 | 2015 | 8532 | 0.430 |
Why?
|
| Craniofacial Abnormalities | 9 | 2013 | 253 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 7 | 4 | 2010 | 77 | 0.420 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2017 | 468 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 22 | 8 | 2017 | 97 | 0.410 |
Why?
|
| Rubinstein-Taybi Syndrome | 2 | 2010 | 16 | 0.400 |
Why?
|
| Genetic Loci | 1 | 2015 | 353 | 0.400 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 1823 | 0.400 |
Why?
|
| CREB-Binding Protein | 2 | 2010 | 55 | 0.400 |
Why?
|
| Otx Transcription Factors | 2 | 2014 | 25 | 0.390 |
Why?
|
| Genomic Instability | 7 | 2017 | 245 | 0.390 |
Why?
|
| Genetic Counseling | 8 | 2018 | 237 | 0.390 |
Why?
|
| Genotype | 9 | 2016 | 2590 | 0.380 |
Why?
|
| Transcription Factors | 9 | 2018 | 2423 | 0.380 |
Why?
|
| Nuclear Proteins | 7 | 2018 | 1219 | 0.380 |
Why?
|
| Whole Genome Sequencing | 6 | 2020 | 360 | 0.370 |
Why?
|
| Branchio-Oto-Renal Syndrome | 2 | 2010 | 11 | 0.370 |
Why?
|
| Face | 4 | 2018 | 189 | 0.370 |
Why?
|
| Heart Defects, Congenital | 8 | 2015 | 1874 | 0.360 |
Why?
|
| Recombination, Genetic | 4 | 2015 | 422 | 0.360 |
Why?
|
| Amniocentesis | 9 | 2025 | 77 | 0.350 |
Why?
|
| Uniparental Disomy | 2 | 2025 | 42 | 0.350 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2011 | 49 | 0.340 |
Why?
|
| Isochromosomes | 1 | 2011 | 17 | 0.340 |
Why?
|
| DNA Methylation | 7 | 2019 | 1074 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 8 | 4 | 2022 | 77 | 0.340 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 585 | 0.340 |
Why?
|
| Chromosome Breakpoints | 8 | 2019 | 82 | 0.340 |
Why?
|
| Muscle Hypotonia | 5 | 2013 | 194 | 0.330 |
Why?
|
| DNA Replication | 6 | 2019 | 358 | 0.330 |
Why?
|
| Mutation | 14 | 2018 | 6094 | 0.330 |
Why?
|
| Trans-Activators | 4 | 2015 | 701 | 0.330 |
Why?
|
| Gonadal Dysgenesis, Mixed | 1 | 2010 | 1 | 0.330 |
Why?
|
| Molecular Sequence Data | 18 | 2016 | 3471 | 0.330 |
Why?
|
| Membrane Proteins | 10 | 2018 | 1589 | 0.320 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2010 | 50 | 0.320 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2019 | 3401 | 0.320 |
Why?
|
| Mental Disorders | 7 | 2015 | 899 | 0.310 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2025 | 887 | 0.310 |
Why?
|
| Body Height | 2 | 2011 | 194 | 0.300 |
Why?
|
| Facies | 9 | 2018 | 157 | 0.300 |
Why?
|
| Homologous Recombination | 6 | 2020 | 97 | 0.290 |
Why?
|
| Genetic Variation | 6 | 2013 | 1541 | 0.290 |
Why?
|
| Brain | 8 | 2015 | 3168 | 0.290 |
Why?
|
| Germ Cells | 3 | 2022 | 199 | 0.290 |
Why?
|
| Goldenhar Syndrome | 1 | 2008 | 15 | 0.280 |
Why?
|
| Point Mutation | 2 | 2009 | 332 | 0.280 |
Why?
|
| Williams Syndrome | 2 | 2012 | 42 | 0.280 |
Why?
|
| Pregnancy Outcome | 3 | 2025 | 615 | 0.280 |
Why?
|
| Forkhead Transcription Factors | 4 | 2014 | 373 | 0.270 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 104 | 0.270 |
Why?
|
| Polymerase Chain Reaction | 7 | 2020 | 1456 | 0.270 |
Why?
|
| Genetic Association Studies | 6 | 2019 | 822 | 0.260 |
Why?
|
| Haploinsufficiency | 5 | 2017 | 264 | 0.260 |
Why?
|
| Carrier Proteins | 5 | 2018 | 999 | 0.260 |
Why?
|
| Young Adult | 19 | 2019 | 9988 | 0.250 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2008 | 175 | 0.250 |
Why?
|
| Cell Cycle Proteins | 5 | 2018 | 710 | 0.250 |
Why?
|
| Chorionic Villi Sampling | 5 | 2017 | 44 | 0.250 |
Why?
|
| Fetus | 6 | 2018 | 567 | 0.250 |
Why?
|
| Osseointegration | 1 | 2026 | 4 | 0.250 |
Why?
|
| Hearing Loss | 1 | 2008 | 204 | 0.250 |
Why?
|
| Peri-Implantitis | 1 | 2026 | 2 | 0.250 |
Why?
|
| Chromosomes, Artificial, Bacterial | 6 | 2008 | 87 | 0.240 |
Why?
|
| Dental Implants | 1 | 2026 | 8 | 0.240 |
Why?
|
| Cohort Studies | 13 | 2018 | 5047 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2014 | 121 | 0.240 |
Why?
|
| Monosomy | 1 | 2006 | 24 | 0.240 |
Why?
|
| Genomic Imprinting | 3 | 2019 | 123 | 0.230 |
Why?
|
| Blastocyst | 1 | 2006 | 73 | 0.230 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 307 | 0.230 |
Why?
|
| Social Behavior | 1 | 2007 | 210 | 0.230 |
Why?
|
| Blepharoptosis | 1 | 2006 | 67 | 0.230 |
Why?
|
| Seizures | 7 | 2016 | 874 | 0.230 |
Why?
|
| Child Behavior | 1 | 2007 | 232 | 0.230 |
Why?
|
| Models, Genetic | 7 | 2015 | 748 | 0.230 |
Why?
|
| Congenital Abnormalities | 4 | 2016 | 322 | 0.220 |
Why?
|
| Chromothripsis | 1 | 2025 | 8 | 0.220 |
Why?
|
| Hyperlipidemias | 1 | 2026 | 186 | 0.210 |
Why?
|
| DNA Repair | 3 | 2020 | 571 | 0.210 |
Why?
|
| Alleles | 5 | 2018 | 1677 | 0.210 |
Why?
|
| DNA End-Joining Repair | 2 | 2020 | 34 | 0.200 |
Why?
|
| Receptors, Cell Surface | 3 | 2012 | 420 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2008 | 34 | 0.190 |
Why?
|
| Nursing Homes | 1 | 2024 | 88 | 0.190 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 120 | 0.190 |
Why?
|
| INDEL Mutation | 2 | 2020 | 93 | 0.190 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 2594 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2014 | 3753 | 0.190 |
Why?
|
| De Lange Syndrome | 3 | 2018 | 44 | 0.190 |
Why?
|
| Sensitivity and Specificity | 7 | 2009 | 2088 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 13 | 4 | 2014 | 48 | 0.190 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 2 | 2018 | 27 | 0.180 |
Why?
|
| Endogenous Retroviruses | 2 | 2013 | 19 | 0.180 |
Why?
|
| Chromosomes | 2 | 2019 | 120 | 0.180 |
Why?
|
| Diseases in Twins | 2 | 2016 | 87 | 0.180 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 5 | 2011 | 400 | 0.180 |
Why?
|
| Exome | 4 | 2018 | 1066 | 0.180 |
Why?
|
| Genes, X-Linked | 3 | 2017 | 60 | 0.180 |
Why?
|
| Gene Order | 5 | 2013 | 81 | 0.180 |
Why?
|
| Cells, Cultured | 10 | 2015 | 2895 | 0.180 |
Why?
|
| Charcot-Marie-Tooth Disease | 3 | 2015 | 237 | 0.170 |
Why?
|
| Pentobarbital | 1 | 2001 | 21 | 0.170 |
Why?
|
| Wolf-Hirschhorn Syndrome | 2 | 2018 | 8 | 0.170 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 40 | 0.170 |
Why?
|
| Isoflurane | 1 | 2001 | 35 | 0.170 |
Why?
|
| Pregnancy Trimester, First | 3 | 2018 | 118 | 0.170 |
Why?
|
| Fluorescent Dyes | 2 | 2016 | 245 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2001 | 26 | 0.170 |
Why?
|
| Anesthetics, Inhalation | 1 | 2001 | 42 | 0.170 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 4 | 2014 | 52 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 352 | 0.160 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2021 | 68 | 0.160 |
Why?
|
| Animals | 21 | 2026 | 33796 | 0.160 |
Why?
|
| Twins | 2 | 2000 | 71 | 0.160 |
Why?
|
| Tumor Burden | 1 | 2021 | 234 | 0.160 |
Why?
|
| Lymph Node Excision | 1 | 2021 | 158 | 0.160 |
Why?
|
| DNA-Binding Proteins | 5 | 2018 | 1947 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 1 | 2001 | 133 | 0.160 |
Why?
|
| Inheritance Patterns | 4 | 2020 | 127 | 0.160 |
Why?
|
| Hydatidiform Mole | 1 | 2000 | 19 | 0.160 |
Why?
|
| Abortion, Habitual | 1 | 2019 | 15 | 0.150 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 424 | 0.150 |
Why?
|
| Disease | 2 | 2012 | 122 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 102 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 4 | 2018 | 322 | 0.150 |
Why?
|
| Neural Cell Adhesion Molecules | 3 | 2018 | 18 | 0.150 |
Why?
|
| Antigens, Nuclear | 2 | 2018 | 52 | 0.150 |
Why?
|
| Hand Deformities, Congenital | 3 | 2018 | 94 | 0.150 |
Why?
|
| Multigene Family | 2 | 2011 | 289 | 0.150 |
Why?
|
| Syndactyly | 2 | 2010 | 24 | 0.140 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 2019 | 330 | 0.140 |
Why?
|
| Neurofibromatosis 1 | 1 | 1999 | 70 | 0.140 |
Why?
|
| Genetic Markers | 5 | 2014 | 591 | 0.140 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2018 | 18 | 0.140 |
Why?
|
| Dementia | 1 | 2024 | 434 | 0.140 |
Why?
|
| Biological Variation, Population | 1 | 2018 | 27 | 0.140 |
Why?
|
| Anesthesia | 1 | 2001 | 209 | 0.140 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2018 | 23 | 0.140 |
Why?
|
| Genetic Carrier Screening | 1 | 2018 | 66 | 0.140 |
Why?
|
| Embryonic Development | 2 | 2017 | 201 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 3 | 2018 | 260 | 0.140 |
Why?
|
| Gametogenesis | 2 | 2017 | 26 | 0.140 |
Why?
|
| Short Rib-Polydactyly Syndrome | 1 | 2018 | 2 | 0.140 |
Why?
|
| Turner Syndrome | 4 | 2017 | 44 | 0.140 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2018 | 2 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2018 | 77 | 0.130 |
Why?
|
| RNA, Messenger | 5 | 2015 | 2552 | 0.130 |
Why?
|
| Neurofibromatosis 2 | 1 | 2017 | 12 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2016 | 251 | 0.130 |
Why?
|
| Polyhydramnios | 1 | 2018 | 52 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2016 | 65 | 0.130 |
Why?
|
| Peptide Termination Factors | 1 | 2017 | 16 | 0.130 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 397 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2025 | 17516 | 0.130 |
Why?
|
| Alu Elements | 2 | 2015 | 66 | 0.130 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2017 | 54 | 0.130 |
Why?
|
| Down Syndrome | 3 | 2017 | 234 | 0.130 |
Why?
|
| Prader-Willi Syndrome | 3 | 2017 | 62 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2014 | 617 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2008 | 166 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 755 | 0.120 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 776 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 2 | 2015 | 86 | 0.120 |
Why?
|
| Family | 3 | 2024 | 584 | 0.120 |
Why?
|
| Pelizaeus-Merzbacher Disease | 2 | 2006 | 22 | 0.120 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2006 | 28 | 0.120 |
Why?
|
| Homozygote | 2 | 2019 | 535 | 0.120 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2014 | 51 | 0.120 |
Why?
|
| Spine | 3 | 2015 | 151 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 25 | 0.120 |
Why?
|
| Middle Aged | 15 | 2021 | 28366 | 0.120 |
Why?
|
| Sex Chromosomes | 2 | 2021 | 29 | 0.120 |
Why?
|
| Gibberellins | 1 | 2015 | 2 | 0.120 |
Why?
|
| Maternal Age | 4 | 2014 | 133 | 0.120 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2015 | 9 | 0.120 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 15 | 0.120 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2015 | 5 | 0.110 |
Why?
|
| Mutation Rate | 2 | 2013 | 68 | 0.110 |
Why?
|
| Myelin Proteins | 1 | 2015 | 79 | 0.110 |
Why?
|
| Catenins | 1 | 2015 | 3 | 0.110 |
Why?
|
| Wounds, Stab | 1 | 2015 | 35 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 85 | 0.110 |
Why?
|
| Sex Characteristics | 3 | 2015 | 323 | 0.110 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 60 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 93 | 0.110 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 42 | 0.110 |
Why?
|
| Multiple Trauma | 1 | 2015 | 62 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 966 | 0.110 |
Why?
|
| Cell Line | 3 | 2014 | 2557 | 0.110 |
Why?
|
| Penetrance | 3 | 2011 | 108 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2015 | 84 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 393 | 0.110 |
Why?
|
| R-SNARE Proteins | 1 | 2014 | 21 | 0.110 |
Why?
|
| Metaphase | 4 | 2008 | 32 | 0.110 |
Why?
|
| Urogenital System | 1 | 2014 | 33 | 0.110 |
Why?
|
| Vascular System Injuries | 1 | 2015 | 57 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 359 | 0.100 |
Why?
|
| Nails, Malformed | 1 | 2013 | 6 | 0.100 |
Why?
|
| Benzoxazines | 1 | 2014 | 22 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2013 | 269 | 0.100 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 41 | 0.100 |
Why?
|
| Repressor Proteins | 3 | 2010 | 765 | 0.100 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2016 | 977 | 0.100 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2014 | 31 | 0.100 |
Why?
|
| Abortion, Spontaneous | 2 | 1992 | 83 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 2896 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2013 | 54 | 0.100 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2013 | 25 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 1313 | 0.100 |
Why?
|
| Algorithms | 2 | 2025 | 1659 | 0.100 |
Why?
|
| Scoliosis | 1 | 2015 | 152 | 0.100 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 110 | 0.100 |
Why?
|
| Internationality | 1 | 2013 | 128 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 299 | 0.100 |
Why?
|
| Zebrafish | 4 | 2017 | 417 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 679 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 62 | 0.090 |
Why?
|
| Receptors, Nicotinic | 2 | 2010 | 113 | 0.090 |
Why?
|
| Cleft Palate | 1 | 2016 | 219 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2014 | 645 | 0.090 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2009 | 14 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 93 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2015 | 215 | 0.090 |
Why?
|
| Parents | 2 | 2018 | 1106 | 0.090 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 158 | 0.090 |
Why?
|
| Munc18 Proteins | 1 | 2012 | 20 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2013 | 195 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 168 | 0.090 |
Why?
|
| Aortic Coarctation | 1 | 2013 | 97 | 0.090 |
Why?
|
| Recurrence | 3 | 2014 | 1470 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 156 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 154 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.090 |
Why?
|
| Culture Techniques | 1 | 1991 | 73 | 0.090 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2009 | 91 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 372 | 0.090 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 72 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 238 | 0.090 |
Why?
|
| Mesoderm | 1 | 1992 | 104 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2020 | 731 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2024 | 1449 | 0.090 |
Why?
|
| Estrogens | 1 | 2014 | 427 | 0.090 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 26 | 0.090 |
Why?
|
| X Chromosome | 3 | 2008 | 326 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 67 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 172 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 102 | 0.090 |
Why?
|
| Organ Size | 1 | 2012 | 412 | 0.090 |
Why?
|
| Hemophilia A | 1 | 2011 | 28 | 0.090 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 450 | 0.090 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 148 | 0.090 |
Why?
|
| Hong Kong | 2 | 2025 | 21 | 0.080 |
Why?
|
| Disease Management | 1 | 2015 | 556 | 0.080 |
Why?
|
| Malformations of Cortical Development | 1 | 2011 | 60 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2012 | 423 | 0.080 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 35 | 0.080 |
Why?
|
| Pseudogenes | 1 | 2011 | 50 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2015 | 901 | 0.080 |
Why?
|
| Cytogenetics | 2 | 2005 | 13 | 0.080 |
Why?
|
| Sexual Development | 1 | 2010 | 23 | 0.080 |
Why?
|
| Horner Syndrome | 1 | 2010 | 13 | 0.080 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2010 | 12 | 0.080 |
Why?
|
| Contrast Media | 2 | 2011 | 479 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 106 | 0.080 |
Why?
|
| MADS Domain Proteins | 1 | 2010 | 3 | 0.080 |
Why?
|
| Mothers | 1 | 2014 | 374 | 0.080 |
Why?
|
| Endocrine System | 1 | 2010 | 18 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 76 | 0.080 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 14 | 0.080 |
Why?
|
| Lyases | 1 | 2010 | 12 | 0.080 |
Why?
|
| Spasms, Infantile | 1 | 2012 | 165 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2013 | 345 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2015 | 528 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2012 | 411 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 2099 | 0.080 |
Why?
|
| Cloaca | 1 | 2010 | 13 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2011 | 1366 | 0.080 |
Why?
|
| Anus, Imperforate | 1 | 2010 | 19 | 0.080 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2013 | 263 | 0.080 |
Why?
|
| HIV-1 | 1 | 2014 | 490 | 0.080 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2010 | 30 | 0.080 |
Why?
|
| Oligospermia | 1 | 2010 | 65 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 595 | 0.080 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 27 | 0.080 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 50 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2010 | 97 | 0.080 |
Why?
|
| PAX6 Transcription Factor | 2 | 2010 | 36 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 294 | 0.080 |
Why?
|
| Hernia, Umbilical | 1 | 2010 | 42 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2010 | 152 | 0.080 |
Why?
|
| Fetal Growth Retardation | 2 | 2016 | 253 | 0.080 |
Why?
|
| Mitotic Index | 1 | 1989 | 17 | 0.080 |
Why?
|
| Mice | 11 | 2017 | 18207 | 0.080 |
Why?
|
| Paired Box Transcription Factors | 2 | 2010 | 72 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 2293 | 0.080 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 131 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 48 | 0.070 |
Why?
|
| Azoospermia | 1 | 2010 | 54 | 0.070 |
Why?
|
| Prognosis | 5 | 2019 | 4859 | 0.070 |
Why?
|
| Nucleolus Organizer Region | 1 | 1989 | 3 | 0.070 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 1989 | 20 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 56 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2011 | 152 | 0.070 |
Why?
|
| Heterozygote | 3 | 2020 | 725 | 0.070 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2014 | 107 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 1989 | 49 | 0.070 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 14 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2013 | 758 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2009 | 231 | 0.070 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 28 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 82 | 0.070 |
Why?
|
| Mitosis | 1 | 1989 | 192 | 0.070 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 140 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2012 | 352 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 86 | 0.070 |
Why?
|
| Mutism | 1 | 2008 | 29 | 0.070 |
Why?
|
| RNA, Small Nucleolar | 1 | 2008 | 16 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 109 | 0.070 |
Why?
|
| Eye Proteins | 2 | 2010 | 225 | 0.070 |
Why?
|
| Nervous System Malformations | 1 | 2009 | 136 | 0.070 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2008 | 74 | 0.070 |
Why?
|
| Aged | 7 | 2024 | 20859 | 0.070 |
Why?
|
| Failure to Thrive | 1 | 2008 | 87 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1483 | 0.070 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2007 | 15 | 0.070 |
Why?
|
| Infertility, Male | 1 | 2011 | 296 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2007 | 91 | 0.070 |
Why?
|
| DNA Mutational Analysis | 4 | 2010 | 780 | 0.070 |
Why?
|
| Language Disorders | 1 | 2007 | 22 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 33 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2007 | 77 | 0.060 |
Why?
|
| Speech Disorders | 1 | 2007 | 46 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 311 | 0.060 |
Why?
|
| Disorders of Sex Development | 1 | 2007 | 69 | 0.060 |
Why?
|
| Karyotype | 2 | 2016 | 30 | 0.060 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2026 | 6 | 0.060 |
Why?
|
| Angelman Syndrome | 2 | 2017 | 67 | 0.060 |
Why?
|
| Decidua | 1 | 1987 | 144 | 0.060 |
Why?
|
| Lymphocytes | 3 | 2015 | 348 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 217 | 0.060 |
Why?
|
| Heterochromatin | 1 | 2006 | 53 | 0.060 |
Why?
|
| Computational Biology | 1 | 2011 | 861 | 0.060 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2009 | 216 | 0.060 |
Why?
|
| Uterus | 1 | 2010 | 542 | 0.060 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 2332 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 422 | 0.060 |
Why?
|
| GTPase-Activating Proteins | 2 | 2018 | 85 | 0.060 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 151 | 0.060 |
Why?
|
| Trisomy 13 Syndrome | 2 | 2017 | 20 | 0.060 |
Why?
|
| Trisomy 18 Syndrome | 2 | 2017 | 17 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 106 | 0.060 |
Why?
|
| Biopsy | 2 | 2006 | 1241 | 0.060 |
Why?
|
| Embryo Transfer | 1 | 2006 | 49 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2013 | 583 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 136 | 0.060 |
Why?
|
| Radiography | 3 | 2015 | 743 | 0.060 |
Why?
|
| WT1 Proteins | 1 | 2005 | 23 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2008 | 324 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 979 | 0.060 |
Why?
|
| Mitochondria | 1 | 2011 | 777 | 0.060 |
Why?
|
| Biomarkers, Tumor | 2 | 2011 | 1586 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2026 | 180 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 618 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2026 | 195 | 0.060 |
Why?
|
| Neoplasms | 2 | 2011 | 2960 | 0.050 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 2 | 2017 | 15 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2007 | 306 | 0.050 |
Why?
|
| Siblings | 2 | 2018 | 201 | 0.050 |
Why?
|
| Fathers | 2 | 2007 | 74 | 0.050 |
Why?
|
| Klebsiella Infections | 1 | 2004 | 58 | 0.050 |
Why?
|
| Incidence | 2 | 2025 | 3316 | 0.050 |
Why?
|
| CpG Islands | 2 | 2016 | 334 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1264 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2025 | 6438 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2008 | 574 | 0.050 |
Why?
|
| Auditory Threshold | 1 | 2001 | 15 | 0.040 |
Why?
|
| HIV Infections | 1 | 2014 | 2030 | 0.040 |
Why?
|
| Megalencephaly | 2 | 2012 | 59 | 0.040 |
Why?
|
| Vacuum | 1 | 2021 | 12 | 0.040 |
Why?
|
| State Medicine | 1 | 2021 | 23 | 0.040 |
Why?
|
| England | 1 | 2021 | 58 | 0.040 |
Why?
|
| Cats | 1 | 2001 | 115 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2015 | 3362 | 0.040 |
Why?
|
| Axilla | 1 | 2021 | 43 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2001 | 90 | 0.040 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2021 | 33 | 0.040 |
Why?
|
| Mastectomy | 1 | 2021 | 74 | 0.040 |
Why?
|
| DNA Breaks | 2 | 2012 | 25 | 0.040 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 37 | 0.040 |
Why?
|
| Ultrasonography | 1 | 1985 | 955 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2001 | 249 | 0.040 |
Why?
|
| Reaction Time | 1 | 2001 | 152 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 1362 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2015 | 403 | 0.040 |
Why?
|
| Menotropins | 1 | 2000 | 1 | 0.040 |
Why?
|
| Mammography | 1 | 2021 | 123 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2018 | 600 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1486 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1206 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2000 | 39 | 0.040 |
Why?
|
| Mesencephalon | 1 | 1999 | 38 | 0.040 |
Why?
|
| Palliative Care | 1 | 2024 | 445 | 0.040 |
Why?
|
| Breast | 1 | 2021 | 214 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 1999 | 68 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 144 | 0.040 |
Why?
|
| Haplotypes | 1 | 2020 | 515 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 625 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 1 | 2018 | 16 | 0.040 |
Why?
|
| Hypotrichosis | 1 | 2018 | 8 | 0.040 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2018 | 9 | 0.040 |
Why?
|
| Genetic Background | 1 | 2018 | 7 | 0.040 |
Why?
|
| SMARCB1 Protein | 1 | 2018 | 41 | 0.040 |
Why?
|
| Pregnancy, High-Risk | 2 | 1988 | 39 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 5162 | 0.040 |
Why?
|
| Patched Receptors | 2 | 2008 | 27 | 0.030 |
Why?
|
| Micrognathism | 1 | 2018 | 64 | 0.030 |
Why?
|
| Patched-1 Receptor | 2 | 2008 | 38 | 0.030 |
Why?
|
| Family Health | 2 | 2010 | 241 | 0.030 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2017 | 4 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2018 | 122 | 0.030 |
Why?
|
| Chromosome Painting | 2 | 2008 | 14 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1877 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 134 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2017 | 20 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2009 | 252 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 1999 | 202 | 0.030 |
Why?
|
| Neck | 1 | 2018 | 140 | 0.030 |
Why?
|
| Human Genome Project | 1 | 2017 | 54 | 0.030 |
Why?
|
| Epigenomics | 1 | 2018 | 179 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 235 | 0.030 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2016 | 18 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 416 | 0.030 |
Why?
|
| Microsatellite Repeats | 2 | 2007 | 205 | 0.030 |
Why?
|
| Cell Division | 2 | 2014 | 718 | 0.030 |
Why?
|
| Choanal Atresia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2398 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1339 | 0.030 |
Why?
|
| Cerebellum | 1 | 1999 | 440 | 0.030 |
Why?
|
| Survival Rate | 2 | 2011 | 2110 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 1999 | 1487 | 0.030 |
Why?
|
| Pregnancy, Twin | 1 | 2016 | 192 | 0.030 |
Why?
|
| Problem Behavior | 1 | 2015 | 39 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 257 | 0.030 |
Why?
|
| Polyadenylation | 1 | 2015 | 47 | 0.030 |
Why?
|
| Genome | 1 | 2017 | 453 | 0.030 |
Why?
|
| Asialoglycoprotein Receptor | 1 | 2014 | 5 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 808 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 141 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2014 | 15 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2014 | 43 | 0.030 |
Why?
|
| Dishevelled Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Genitalia | 1 | 2014 | 39 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1995 | 62 | 0.030 |
Why?
|
| Aortography | 1 | 2015 | 151 | 0.030 |
Why?
|
| Obesity | 1 | 2006 | 2381 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 327 | 0.030 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 553 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 159 | 0.030 |
Why?
|
| Actin-Related Protein 2-3 Complex | 1 | 2013 | 11 | 0.030 |
Why?
|
| Alkynes | 1 | 2014 | 26 | 0.030 |
Why?
|
| Genes, Duplicate | 1 | 2013 | 16 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2013 | 29 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2015 | 177 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2015 | 172 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2013 | 38 | 0.030 |
Why?
|
| Lithium | 1 | 2013 | 66 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 304 | 0.030 |
Why?
|
| Hyperkinesis | 1 | 2013 | 27 | 0.030 |
Why?
|
| Cyclopropanes | 1 | 2014 | 67 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 411 | 0.020 |
Why?
|
| Risk Factors | 3 | 2016 | 10941 | 0.020 |
Why?
|
| Base Composition | 1 | 2013 | 66 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2013 | 101 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 51 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2013 | 112 | 0.020 |
Why?
|
| Y Chromosome | 2 | 1991 | 47 | 0.020 |
Why?
|
| Cognition | 1 | 2018 | 810 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2013 | 140 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2014 | 220 | 0.020 |
Why?
|
| Cell Survival | 1 | 2015 | 830 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1995 | 146 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2013 | 245 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 1995 | 269 | 0.020 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 16 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 722 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Endoglin | 1 | 2012 | 30 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 766 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2014 | 452 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1995 | 238 | 0.020 |
Why?
|
| Nerve Net | 1 | 2015 | 256 | 0.020 |
Why?
|
| Dwarfism | 1 | 2013 | 104 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 93 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 382 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 84 | 0.020 |
Why?
|
| Fertility | 1 | 2014 | 260 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 104 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 1166 | 0.020 |
Why?
|
| Ofloxacin | 1 | 1991 | 29 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1611 | 0.020 |
Why?
|
| Spectrin | 1 | 2012 | 70 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 501 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 314 | 0.020 |
Why?
|
| Diaphragmatic Eventration | 1 | 2011 | 7 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 34 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 45 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 450 | 0.020 |
Why?
|
| Leucovorin | 1 | 2011 | 53 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 221 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 361 | 0.020 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2011 | 10 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 407 | 0.020 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 629 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1594 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2011 | 60 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 32 | 0.020 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 16 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2011 | 132 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2010 | 22 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 426 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 525 | 0.020 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2010 | 3 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 488 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 1991 | 104 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1999 | 3795 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 500 | 0.020 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2010 | 9 | 0.020 |
Why?
|
| Anal Canal | 1 | 2011 | 86 | 0.020 |
Why?
|
| MEF2 Transcription Factors | 1 | 2010 | 34 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 4664 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 922 | 0.020 |
Why?
|
| Genes, Wilms Tumor | 1 | 2010 | 4 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2011 | 204 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2010 | 14 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 2337 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 170 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 2010 | 20 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 57 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 69 | 0.020 |
Why?
|
| Bladder Exstrophy | 1 | 2010 | 13 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2012 | 254 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 44 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 2011 | 117 | 0.020 |
Why?
|
| Coloboma | 1 | 2010 | 40 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 1320 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 404 | 0.020 |
Why?
|
| Hippocampus | 1 | 2015 | 792 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2010 | 59 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2009 | 35 | 0.020 |
Why?
|
| Microdissection | 1 | 2009 | 13 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 55 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 52 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 1343 | 0.020 |
Why?
|
| Trachea | 1 | 2011 | 206 | 0.020 |
Why?
|
| Esophagus | 1 | 2011 | 231 | 0.020 |
Why?
|
| Capillaries | 1 | 2009 | 64 | 0.020 |
Why?
|
| Sister Chromatid Exchange | 1 | 2008 | 15 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2008 | 30 | 0.020 |
Why?
|
| Culture Media | 1 | 1989 | 169 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 3382 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 227 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2008 | 35 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2008 | 33 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 1609 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
| Ectodysplasins | 1 | 2008 | 7 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 44 | 0.020 |
Why?
|
| Hair Color | 1 | 2008 | 12 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2008 | 15 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2008 | 51 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 68 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 356 | 0.020 |
Why?
|
| Reference Standards | 1 | 2009 | 232 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1989 | 166 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 785 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2008 | 39 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 86 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2008 | 40 | 0.020 |
Why?
|
| Color | 1 | 2008 | 30 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2008 | 40 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2008 | 54 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2464 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2009 | 287 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 152 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1988 | 161 | 0.020 |
Why?
|
| Hirsutism | 1 | 2007 | 22 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1988 | 117 | 0.020 |
Why?
|
| Autoantigens | 1 | 2008 | 100 | 0.020 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2007 | 7 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 6786 | 0.020 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2007 | 36 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 2009 | 166 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 1991 | 428 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2062 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 289 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 780 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 566 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 245 | 0.020 |
Why?
|
| RNA, Long Noncoding | 1 | 2009 | 217 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 336 | 0.020 |
Why?
|
| Rett Syndrome | 1 | 2009 | 229 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 20 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 828 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 123 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1279 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 677 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2008 | 323 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2008 | 811 | 0.010 |
Why?
|
| Tuberculosis | 1 | 1991 | 554 | 0.010 |
Why?
|
| Bisbenzimidazole | 1 | 1985 | 3 | 0.010 |
Why?
|
| Azure Stains | 1 | 1985 | 5 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 343 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 2012 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1985 | 55 | 0.010 |
Why?
|
| Aging | 1 | 2012 | 1242 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1988 | 852 | 0.010 |
Why?
|
| Kidney | 1 | 2011 | 1277 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 1122 | 0.010 |
Why?
|
| Texas | 1 | 2012 | 3643 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 974 | 0.010 |
Why?
|
| Trophoblasts | 1 | 1983 | 114 | 0.010 |
Why?
|
| Gestational Age | 1 | 1985 | 1213 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 697 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6197 | 0.010 |
Why?
|
| Binomial Distribution | 1 | 1999 | 5 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3711 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 1127 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 564 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 1976 | 12 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 4669 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12840 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1995 | 101 | 0.010 |
Why?
|
| Probability | 1 | 1994 | 305 | 0.010 |
Why?
|
| Cholesterol | 1 | 1976 | 538 | 0.010 |
Why?
|
| DNA Probes | 1 | 1991 | 118 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1991 | 319 | 0.010 |
Why?
|
| Sex Determination Analysis | 1 | 1983 | 15 | 0.000 |
Why?
|
| Cytological Techniques | 1 | 1983 | 18 | 0.000 |
Why?
|
| Cytodiagnosis | 1 | 1983 | 18 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1983 | 809 | 0.000 |
Why?
|
| Placenta | 1 | 1983 | 501 | 0.000 |
Why?
|
| Twins, Dizygotic | 1 | 1976 | 46 | 0.000 |
Why?
|
| Lipoproteins, VLDL | 1 | 1976 | 53 | 0.000 |
Why?
|
| Lipoproteins, HDL | 1 | 1976 | 97 | 0.000 |
Why?
|
| Lipoproteins, LDL | 1 | 1976 | 119 | 0.000 |
Why?
|
| Twins, Monozygotic | 1 | 1976 | 124 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1976 | 936 | 0.000 |
Why?
|